Step right up, ladies and gentlemen, and welcome to the hottest new spot in town: The Weight-Loss Casino! Here, you don’t ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

While GLP-1 drugs are currently available in the market, the Food and Drug Administration (FDA) had declared a shortage of semaglutide supply since 2022 after its popularity skyrocketed following news ...

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...

The research was led by Dr Marcus Kaiser from the School of Medicine at the University. He said: "Providing accurate information to patients significantly improved positive perception of ...

(Bassett, 2/25) The Hill: Drug Compounders Sue Over Weight Loss Drugs’ Removal From FDA Shortage List A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug ...

Whether you’ve just started taking semaglutide for weight loss or are considering other GLP-1 medications, you likely have many questions. These include the optimal dose, when to slow down or ...

Starbucks plans to lay off 1,100 corporate employees globally as new Chairman and CEO Brian Niccol streamlines operations. In a letter to employees released Monday, Niccol said the company will inform ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...